Ogawa, Eiichi http://orcid.org/0000-0002-5082-3967
Nakamuta, Makoto
Koyanagi, Toshimasa
Ooho, Aritsune
Furusyo, Norihiro
Kajiwara, Eiji
Dohmen, Kazufumi
Kawano, Akira
Satoh, Takeaki
Takahashi, Kazuhiro
Azuma, Koichi
Yamashita, Nobuyuki
Yamashita, Naoki
Sugimoto, Rie
Amagase, Hiromasa
Kuniyoshi, Masami
Ichiki, Yasunori
Morita, Chie
Kato, Masaki
Shimoda, Shinji
Nomura, Hideyuki
Hayashi, Jun
,
Funding for this research was provided by:
Gilead Sciences
Article History
Received: 26 February 2021
Accepted: 24 December 2021
First Online: 25 January 2022
Declarations
:
: Eiichi Ogawa has received speaker fees from Gilead Sciences and AbbVie. Makoto Nakamuta, Toshimasa Koyanagi, Aritsune Ooho, Norihiro Furusyo, Eiji Kajiwara, Kazufumi Dohmen, Akira Kawano, Takeaki Satoh, Kazuhiro Takahashi, Koichi Azuma, Nobuyuki Yamashita, Naoki Yamashita, Rie Sugimoto, Hiromasa Amagase, Masami Kuniyoshi, Yasunori Ichiki, Chie Morita, Masaki Kato, Shinji Shimoda, Hideyuki Nomura, and Jun Hayashi declare that they have no conflicts of interest.
: The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and the STROBE statement. It was approved by the Ethics Committees of Kyushu University Hospital and each study site and is registered as a clinical study on the University Hospital Medical Information Network (ID 000034696).